World Leaders Unite to Combat Antibiotic Resistance

World Leaders Unite to Combat Antimicrobial Resistance

In a major breakthrough, world leaders have committed to scaling up efforts to combat antimicrobial resistance (AMR), a growing threat to modern medicine. The United Nations General Assembly in New York has approved a new political declaration, marking a significant step towards addressing this global health crisis.

AMR, caused by the misuse and overuse of antimicrobial medicines, threatens to undo a century of medical progress. It could return us to the pre-antibiotic era, where infections that are treatable today could become much harder to treat and potentially deadly tomorrow. The consequences are dire, with over a million deaths attributed to AMR each year, and an escalating death toll projected over the coming decades.

The burden of treatment-resistant infections falls heaviest on low- and middle-income countries (LMICs), where access to clean water, healthcare, and diagnostic tools is limited. Sepsis in newborns and routine medical procedures are particularly at risk, making it crucial to address the crisis in these countries.

The declaration includes commitments to reduce global deaths associated with drug-resistant bacteria by 10% by 2030 and ensure that at least 70% of antibiotics used for human health globally belong to the safer WHO Access group. Projections show that many of these deaths are avoidable, including by ensuring access to life-saving antimicrobial medicines in LMICs.

The investment case for AMR is clear, with estimates suggesting that inaction could lead to additional healthcare expenditures of up to US$ 412 billion annually in the next decade. However, implementing critical AMR interventions is a "best buy," with a return on investment of 7 to 13 USD for every one USD spent.

To bring this vision to life, the meeting’s opening and closing segments will feature statements from AMR survivors, Ella and John. Ella lives with cystic fibrosis and has had to rely on experimental treatment after contracting a severe drug-resistant infection. John’s surgery for a simple hip fracture turned into a year-long hospital stay after the incision site became infected and resistant to multiple drugs.

A successful response to AMR relies on political commitment, sustainable financing, measuring progress with accountability, and placing those affected at the centre of the response. The world must come together to address this crisis, ensuring that the tools and resources are available to combat AMR and protect public health.